Machina Capital’s ResMed RMD Stock Holding History

Machina Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,685	Closed	-$1.5M	–	386
2025 Q1	$1.5M	Buy	+6,685	New	+$1.56M	0.44%	84
2024 Q4	–	Sell	-884	Closed	-$216K	–	351
2024 Q3	$216K	Buy	+884	New	+$198K	0.09%	265
2023 Q3	–	Sell	-8,351	Closed	-$1.82M	–	347
2023 Q2	$1.82M	Buy	8,351 +7,251	+659%	+$1.62M	1.04%	13
2023 Q1	$241K	Sell	1,100 -491	-31%	-$107K	0.21%	169
2022 Q4	$331K	Buy	+1,591	New	+$350K	0.61%	74
2022 Q1	–	Sell	-900	Closed	-$234K	–	178
2021 Q4	$234K	Buy	+900	New	+$234K	0.56%	101
2021 Q3	–	Sell	-1,300	Closed	-$320K	–	195
2021 Q2	$320K	Buy	+1,300	New	+$273K	0.54%	84
2019 Q2	–	Sell	-4,049	Closed	-$421K	–	609
2019 Q1	$421K	Buy	+4,049	New	+$418K	0.17%	179

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Machina Capital's RMD Position: Q2 2025 in Review

Machina Capital sold out of ResMed (RMD) in Q2 2025, closing a stake of 6,685 shares — an estimated $1.5M sold.

Machina Capital first reported a position in RMD in Q1 2019 and held it in 8 quarters. The position peaked at $1.82M in Q2 2023. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Machina Capital reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Machina Capital sold 6,685 ResMed shares in Q2 2025, an estimated $1.5M.
Machina Capital first reported a position in ResMed in Q1 2019 and held it in 8 quarters.
Machina Capital's ResMed position peaked at $1.82M in Q2 2023.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Machina Capital's 13F filing for Q2 2025, filed 5 Aug 2025.